FarshchianART
MIAMI, FL / ACCESSWIRE / December 18, 2023 / Mahmoud Farshchian, 93, the renowned Iranian artist, continues to captivate art enthusiasts with his exceptional talent and artistic vision. FarshchianART -- a foundation created by the Farschian family and dedicated to collecting, exhibiting, preserving, and interpreting the art and archives of Mahmoud Farshchian -- has announced that one of his paintings inspired by the original "Fifth Day of Creation" fetched an impressive price of $120,000 at a prestigious auction held at Sotheby's. This sale highlights the enduring appeal and value of Farshchian's works in the art market.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.Image of Painter
"Fifth Day Of Creation" - 6x4 feet - circa 1980s - estimated at 1.8 million USD, captured the adoration of collector Stuart Cary Welch. He commissioned Farshchian, who painted an inspired painting of 3x2 feet.
When Welch saw Farshchian's collection, he stated: "Once experienced, Farshchian's pictures tend to linger in our minds, revealing new facets…. Through his enticing, sometimes upsetting worlds, Farshchian's brush dances to the rhythms of traditional vegetal arabesques."
-- DR. STUART CARY WELCH, Curator - Harvard University Art Museums, 1970-1995
Mahmoud Farshchian, who is currently 94 years old and residing in Englewood Cliffs, NJ, has been recognized as a master of Persian miniature painting for several decades. His unique style, blending traditional Persian elements with contemporary influences, has garnered international acclaim. With a career spanning over six decades, Farshchian's artworks have become highly sought after by collectors and art enthusiasts worldwide.
Leila Farshchian, the director of Farshchianart.com, expressed her delight at the auction result, stating, "We are thrilled to witness the continued appreciation of my father's work in the art world. The sale of the inspired commissioned 'Fifth Day of Creation' for $120,000 reaffirms the enduring value of Mahmoud Farshchian's artistic legacy. His ability to evoke profound emotions through his brushstrokes is truly remarkable."
It is worth noting that Farshchian's paintings have achieved even higher prices in the United States, with some reaching up to $1,800,000. The artist's ability to capture the essence of Persian culture, history, and spirituality has resonated deeply with collectors, establishing Farshchian as an icon of Persian art.
For more information about Mahmoud Farshchian and his extraordinary artworks, please visit Farshchianart.com.
###
About Mahmoud Farshchian:
Mahmoud Farshchian is a renowned Iranian artist known for his mastery of Persian miniature painting. With a career spanning over six decades, Farshchian's works have been exhibited and collected in prestigious galleries and museums worldwide. His unique artistic style combines traditional Persian techniques with contemporary influences, creating captivating and evocative compositions.
Media Contact: https://www.farshchianart.com
Contact Information
Leila Farshchian
Director
leila@farshchianart.com
201-777-4557
Related Images
SOURCE: FarshchianART
To view this piece of content from stats.newswire.com, please give your consent at the top of this page.View the original press release on newswire.com.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Formerra to Supply Foster Medical Compounds Across the Americas15.7.2025 16:45:00 CEST | Press release
Following GEON's acquisition of Foster, LLC, this new agreement expands Formerra's healthcare polymer portfolio with life-saving medical compounds. ROMEOVILLE, IL / ACCESS Newswire / July 15, 2025 / Formerra, a leader in performance materials distribution, today announced an agreement with GEON® Performance Solutions that designates Formerra as the preferred distributor of Foster®, LLC medical compounds in North America and South America. The agreement follows GEON's acquisition of Foster, LLC, and builds on Formerra's long-standing, global partnership with GEON for flexible and rigid PVC and filled polypropylene materials. "This expanded partnership equips our customers with a broader set of proven medical-grade solutions while leveraging Formerra's technical guidance and robust supply-chain capabilities," said Kelly Wessner, Vice President, Key Accounts, Formerra. "Foster's brand strength and GEON's investment momentum create powerful growth potential for these materials and our cust
FairWinds Migrates from .COM to .FAIRWINDS, Showcasing Leadership in Strategic Internet Addressing15.7.2025 16:00:00 CEST | Press release
WASHINGTON, DC / ACCESS Newswire / July 15, 2025 / FairWinds Partners, the world's leading domain name strategy consultancy, has completed the migration of its website from fairwindspartners.com to home.fairwinds. "This transition is more than a domain change. It reflects our belief in the future of .BRAND top-level domains," said FairWinds founder Josh Bourne. "Our move to .FAIRWINDS reinforces the strategic value that these top-level domains offer and our evolution from a pioneering domain name advisory firm to the trusted partner for global brands navigating the digital landscape via the address bar." Unlike second-level domains like google.com, top-level domains reside on the internet's root servers -- the foundation of the internet's naming system. .BRAND top-level domains are not publicly available and are used exclusively by the brand owner. ".BRAND top-level domains provide a powerful way to amplify, control, and secure a brand's digital presence while giving visitors visual pr
QorusDocs Reports 360% Increase in Customers Using AI to Manage Proposals, Acquires Shark Finesse to Build Unified AI-Powered Value and Proposal Platform15.7.2025 13:00:00 CEST | Press release
BELLEVUE, WA / ACCESS Newswire / July 15, 2025 / QorusDocs, an AI-powered proposal management software company that streamlines creation of pitches, proposals and request for proposal (RFP) responses, today announced that its customers' use of AI to manage proposals has grown 360% year over year, and that it has acquired Shark Finesse Ltd, a United Kingdom-based AI-powered customer value management software. "AI is completely transforming how business development teams win business, and QorusDocs is at the forefront," said Ray Meiring, CEO of QorusDocs. "The majority of our customers now rely on AI to manage proposals. We're at a pivotal moment, and with the acquisition of Shark Finesse, we're poised to deliver on companies' full revenue enablement journey, from proving value to winning the deal." QorusDocs Acquires Shark Finesse With Shark Finesse joining QorusDocs, the company's vision is to enable business development and proposal teams to prove value early in the revenue cycle, wit
AATec Medical and Northway Biotech Announce Partnership to Develop Industrial Production Process for ATL-105 Targeting Lung Disease15.7.2025 09:50:00 CEST | Press release
Partnership established to develop and scale production of ATL-105, a novel recombinant version of alpha-1 antitrypsin Lead indication is non-CF bronchiectasis; ATL-105 targets disease drivers through a broad multimodal mechanism of action VILNIUS, LT / ACCESS Newswire / July 15, 2025 / AATec Medical GmbH ("AATec"), a biotech company developing a multi-product platform for the treatment of respiratory diseases, and Northway Biotech ("Northway Biotech" or "NBT"), a global Contract Development and Manufacturing Organization (CDMO), today announced a partnership for manufacturing process development and analytical development of AATec's lead product candidate, ATL-105, a proprietary, inhaled therapy based on recombinant alpha-1 antitrypsin (AAT) for non-cystic fibrosis bronchiectasis (NCFB).AATec Medical and Northway Biotech Announce Partnership Under the agreement, Northway Biotech will leverage its expertise in biologics manufacturing to develop and scale the production process for ATL-
IXOPAY Surges Past 500 Certified Adapters, Solidifies Leadership in Enterprise-Grade Payment Orchestration15.7.2025 06:00:00 CEST | Press release
With 200 PSPs and 300 payment methods, IXOPAY is unlocking faster global expansion, improved approval rates, and full-stack control for enterprise merchants. LEHI, UT / ACCESS Newswire / July 15, 2025 / As global commerce accelerates, enterprise merchants are hitting a wall - their legacy payment stacks weren't built for the scale, complexity, or speed modern commerce demands. To stay competitive, merchants need infrastructure that adapts across markets, providers, and payment methods without costly rewrites or vendor lock-in. IXOPAY, a global leader in enterprise-grade payment orchestration, is addressing that challenge head-on with the announcement it has reached 500 certified adapters, connecting 200 payment service providers (PSPs) and 300 payment methods through a single, vendor-agnostic API. Payment orchestration is rapidly emerging as vital infrastructure for modern payments, and its effectiveness depends on the scale and breadth of the adapter ecosystem. IXOPAY's industry-leadi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom